在ARSB基因中复杂的结构和拼接改变变异的功能分析 面向针对VI型粘多糖症患者的个性化反感性疗法
Igor Bychkov1, Alexandra Filatova2, Galina Baydakova1
1Department of Molecular Mechanisms of Inherited Metabolic Disorders, Research Centre for Medical Genetics, Moscow, Russia.
Human mutation
|July 18, 2025
概括
对VI型粘多糖症 (MPS VI) 的遗传分析可能具有挑战性. 这项研究确定了标准测序遗漏的复杂变异,并提出了反意义疗法,以恢复ARSB基因功能.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 粘多糖症VI型 (MPS VI) 是一种由ARSB基因变异引起的遗传性疾病,导致溶酶体功能障碍.
- 标准基因检测可能无法检测MPS VI的基础复杂变异.
- 识别致病变体对于诊断和治疗开发至关重要.
研究的目的:
- 调查MPS VI的遗传基础,在患者中,无法解释的临床表现.
- 为了识别ARSB基因中常规测序中遗漏的复杂结构变异.
- 探索针对异常拼接的潜在治疗策略.
主要方法:
- 使用全基因组测序和RNA分析来识别致病变异.
- 基于小基因的细胞模型被用来研究对剪接的变异效应.
- 对抗意义分子策略 (修改的U7 snRNA和循环RNA) 进行了治疗潜力的测试.
主要成果:
- 三名MPS VI患者患有复杂的ARSB变异,包括大型内置插入和内基删除,被桑格测序遗漏.
- 确定了一种激活伪外显子和外显子2删除的深层内部变异.
- 反意义分子有效地阻断了伪exons,使野生类型的ARSB mRNA水平增加了大约两倍.
结论:
- 复杂的结构变异和深层内突变可以导致MPS VI并逃避标准遗传检测.
- 用反感性寡核酸向伪子激活显示为MPS VI治疗的前景.
- 这种方法可以恢复具有特定遗传缺陷的患者的功能性ARSBmRNA水平.
更多相关视频
相关概念视频
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
RNA Splicing
57.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K
Protein Complexes with Interchangeable Parts
2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K


